Skip to main content
Norris Cotton Cancer Center
In This Section
Identification and characterization of skin-resident memory T cells in patients with melanoma-associated vitiligo
Principal Investigator (?)
Study Number
Patients with melanoma who develop vitiligo, an autoimmune response, have better rates of survival than those who dont. Some immunotherapy drugs can activate vitiligo, which could potentially improve cancer treatment. The purpose of the study is to learn more about the cells that respond to these immunotherapy drugs by comparing skin cells of melanoma/vitiligo patients to skin cells of people who dont have these conditions. 
Phase (?)
Phase III
Sponsor (?)
Available at the following location(s)


Contact Information

For more information about a clinical trial, clinical trial eligibility, or informed consent, contact our research nurses by phone or email:

Please Note: Any eligibility criteria noted are subject to change. Our research nurses can provide you with the most current eligibility and exclusion criteria. Any study involvement to be undertaken must ultimately be determined on an individual basis.